Study Details

Study ID 1517-CL-0613
Study Title A Phase 3, Randomized, Open-Label, Active-Controlled Study to Evaluate the Efficacy and Safety of Roxadustat in the Maintenance Treatment of Anemia in End Stage Renal Disease Subjects on Stable Dialysis Identifier NCT02278341
Compound Name ASP1517 / roxadustat
Medical Indication or Disease Anemia with chronic kidney disease
Study Sponsor Astellas Pharma Europe B.V.
Collaborator FibroGen
Study Start Date 21-Nov-2014
Study Completion Date 06-Jul-2018
Clinical Study Result
Select the language
Plain Language Summary
Select the language